Related Experiment Video
Updated: May 31, 2026

06:13
Endoscopic Septoplasty with Limited Two-line Resection: Minimally Invasive Surgery for Septal Deviation
Published on: June 20, 2018
CBC-Derived Biomarkers Associated With Recurrence After Sinus Surgery in Chronic Rhinosinusitis
Virat Kirtsreesakul1, Paramee Thongsuksai2, Nuttha Sanghan3
1Department of Otolaryngology, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand.
The Laryngoscope
|May 29, 2026
Summary
Higher absolute eosinophil count (AEC) and systemic immune-inflammation index (SII) predict chronic rhinosinusitis (CRS) recurrence after endoscopic sinus surgery (ESS). AEC offers better long-term risk stratification for CRS patients post-surgery.
Area of Science:
- Otolaryngology
- Immunology
- Medical Biomarkers
Background:
- Chronic rhinosinusitis (CRS) frequently recurs after endoscopic sinus surgery (ESS).
- Limited biomarkers exist for predicting long-term recurrence risk in CRS patients.
- Complete blood count (CBC)-derived markers offer potential for risk stratification.
Purpose of the Study:
- To investigate the association between CBC-derived biomarkers and long-term CRS recurrence post-ESS.
- To evaluate the prognostic value of biomarkers like absolute eosinophil count (AEC) and systemic immune-inflammation index (SII).
Main Methods:
- Retrospective analysis of 543 CRS patients undergoing ESS.
- Time-to-event analysis using Cox regression with LASSO for variable selection.
- Assessment of CBC-derived biomarkers including AEC, SII, and various ratios.
Main Results:
- Higher baseline AEC and SII were independently associated with increased long-term CRS recurrence.
- AEC demonstrated significant incremental prognostic value, improving model discrimination.
- SII showed minimal additional predictive value beyond established clinical factors.
Conclusions:
- Elevated AEC and SII are linked to long-term CRS recurrence after ESS.
- AEC appears to be a more robust predictor of recurrence than SII.
- These biomarkers may indicate inherent host susceptibility rather than active disease processes.
